相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy
Mona W. Ayad et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma
Irit Avivi et al.
LEUKEMIA & LYMPHOMA (2014)
Association of ABCC2-24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia
Yan Liu et al.
PLOS ONE (2014)
A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia
E. Lopez-Lopez et al.
PHARMACOGENOMICS JOURNAL (2013)
Is the MDR1 C3435T Polymorphism Responsible for Oral Mucositis in Children with Acute Lymphoblastic Leukemia?
Kivanc Bektas-Kayhan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue
Patrizia Chiusolo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia
Nina Erculj et al.
LEUKEMIA & LYMPHOMA (2012)
Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
Noha M. EL-Khodary et al.
MEDICAL ONCOLOGY (2012)
Germline genetic variation and treatment response on CCG-1891
Dana M. Sepe et al.
PEDIATRIC BLOOD & CANCER (2012)
Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis
Kalliopi P. Spyridopoulou et al.
PHARMACOGENETICS AND GENOMICS (2012)
Polymorphisms in the methotrexate transport pathway
Elixabet Lopez-Lopez et al.
Pharmacogenetics and Genomics (2012)
Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemia
J. Salazar et al.
PHARMACOGENOMICS JOURNAL (2012)
Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis
Lin Yang et al.
TUMOR BIOLOGY (2012)
Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
Guillermo Gervasini et al.
Frontiers in Genetics (2012)
Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants
Velia D'Angelo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma
Barbara Faganel Kotnik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Role of the Methylenetetrahydrofolate Reductase 677 and 1298 Polymorphisms in Cretan Children with Acute Lymphoblastic Leukemia
Nikolaos V. Karathanasis et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2011)
Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population
Shu-Guang Liu et al.
LEUKEMIA & LYMPHOMA (2011)
Polymorphisms of the SLCO1B1 Gene Predict Methotrexate-Related Toxicity in Childhood Acute Lymphoblastic Leukemia
Elixabet Lopez-Lopez et al.
PEDIATRIC BLOOD & CANCER (2011)
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia
Azza A. G. Tantawy et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
ASSOCIATION OF GENETIC POLYMORPHISMS WITH HEPATOTOXICITY IN PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOMA
Masanori Horinouchi et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2010)
Cancer research: from folate antagonism to molecular targets
Joseph R. Bertino
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Advances in individual prediction of methotrexate toxicity: a review
Kjeld Schmiegelow
BRITISH JOURNAL OF HAEMATOLOGY (2009)
C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation
Elena De Mattia et al.
EUROPEAN JOURNAL OF CANCER (2009)
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival
Alessia Ongaro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression
Ana Patino-Garcia et al.
JOURNAL OF PEDIATRICS (2009)
Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma
Mehmet Kantar et al.
LEUKEMIA & LYMPHOMA (2009)
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research
E. S. Jaffe
Hematology-American Society of Hematology Education Program (2009)
Influence of MTHFR and RFC1 Polymorphisms on Toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma
Noriko Shimasaki et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)
Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors
Kevin R. Krull et al.
JOURNAL OF PEDIATRICS (2008)
Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
L. Huang et al.
LEUKEMIA (2008)
MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients
Patrizia Chiusolo et al.
LEUKEMIA RESEARCH (2007)
Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia
Samart Pakakasama et al.
ANNALS OF HEMATOLOGY (2007)
Ancestry and phannacogenetics of antileukernic drug toxicity
Shinji Kishi et al.
BLOOD (2007)
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival
Donato Gemmati et al.
HAEMATOLOGICA (2007)
Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma
Hiroyuki Imanishi et al.
JOURNAL OF HUMAN GENETICS (2007)
Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico
Guillermo J. Ruiz-Argueles et al.
HEMATOLOGY (2007)
Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia:: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P
Paul C. Nathan et al.
LEUKEMIA & LYMPHOMA (2006)
Methylenetetrahydrofolate reductase C677T polymorphism: Association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in Greek patients
Konstantinos Chatzidakis et al.
PEDIATRIC BLOOD & CANCER (2006)
MTHFR 677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL:: results from 484 patients of multicenter trial NHL-BFM 95
Kathrin Seidemann et al.
ANNALS OF HEMATOLOGY (2006)
Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma
N Shimasaki et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
JCC Rocha et al.
BLOOD (2005)
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia
R Aplenc et al.
CANCER RESEARCH (2005)
SLC19: the folate/thiamine transporter family
V Ganapathy et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
DA Thomas et al.
BLOOD (2004)
Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukeniia
M Krajinovic et al.
BLOOD (2004)
Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia
S Kishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate
P Chiusolo et al.
ANNALS OF ONCOLOGY (2002)
Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia
C Laverdière et al.
BLOOD (2002)
The hyper-CVAD regimen in adult acute lymphocytic leukema
G Garcia-Manero et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy
A Trotti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
